JPRN-UMIN000006154招募中未知
Restoration of Aldosterone Breakthrough by Aliskiren - Restoration of Aldosterone Breakthrough by Aliskiren
Division of Cardiology, Keio University School of Medicine0 个研究点目标入组 200 人开始时间: 2011年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Left ventricular systolic dysfunction (LVEF is under 40% on echocardiography) 2)History of Acute coronary syndrome or stroke within 6 months 3)Serum Cr is over 2.0mg/dl 4)Serum potassium is over 5.0mmol/L 5)Hypertensivity or contraindication to aliskiren 6)Pregnancy or Breastfeeding 7)Inability to obtain informed consent 8)Any conditions not suitable for the participation in this trial judged by the investigator
研究者
相似试验
尚未招募
不适用
Research of Aldosterone Breakthrough by AliskireHypertensionJPRN-UMIN000006974Control of organ function, Kanazawa University Hospital200
尚未招募
不适用
Clinical significance of plasma aldosterone concentration in patients with primary aldosteronismPrimary aldosteronismJPRN-UMIN000016201Department of Metabolic Medicine, Osaka University Graduate School of Medicine750
进行中（未招募）
1 期
Pilot study of aprepitant effect on aldosterone secretion in diabetic patient with hypertension associated with low reniDiabetic patient (diabetes mellitus) with hypertension associated with low reninMedDRA version: 18.1Level: HLTClassification code 10052741Term: Endocrine and metabolic secondary hypertensionSystem Organ Class: 100000004866MedDRA version: 18.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-001501-14-FRRouen University Hospital20
招募中
不适用
Transarterial embolization of aldosterone producing adenoma of the adrenal gland – the DRAMA studyE26.8Other hyperaldosteronismDRKS00023816Klinikum der Universität München, Campus Großhadern19
进行中（未招募）
不适用
Blocage des effets létaux de l'aldostérone dans l'infarctus du myocarde traité ou non par la reperfusion pour améliorer le pronostic et la survie à six mois : Etude randomisée comparant un blocage spécifique de l'aldostérone en plus du traitement usuel au traitement usuel seul débuté dans les 72 premières heures après la survenue d'un infarctus aigu du myocardeALBATROSS - ALBATROSSInfractusMedDRA version: 8.1Level: PTClassification code 10000891Term: IMCEUCTR2008-006857-42-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)